[
    [
        {
            "time": "",
            "original_text": "沃森生物(300142.SZ)合作研发的新型冠状病毒mRNA疫苗获得药物临床试验批件",
            "features": {
                "keywords": [
                    "沃森生物",
                    "mRNA疫苗",
                    "临床试验",
                    "新冠病毒"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "沃森生物(300142.SZ)合作研发的新型冠状病毒mRNA疫苗获得药物临床试验批件",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "医药行业报告：新冠疫苗研发步入关键阶段 - 现有数据怎么看 III期临床如何开展？",
            "features": {
                "keywords": [
                    "新冠疫苗",
                    "III期临床",
                    "研发进展"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药行业报告：新冠疫苗研发步入关键阶段 - 现有数据怎么看 III期临床如何开展？",
                "Correlation": 6,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "时代医药周报 | 上半年医药行业涨幅居首，多方新冠肺炎疫苗研发齐突破",
            "features": {
                "keywords": [
                    "医药行业",
                    "涨幅",
                    "新冠疫苗",
                    "研发突破"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "时代医药周报 | 上半年医药行业涨幅居首，多方新冠肺炎疫苗研发齐突破",
                "Correlation": 5,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 4,
                "Duration": 5,
                "Entity_Density": 2,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "[天风医药 | 周报】国内或将进一步加大检测需求，全球疫情仍未见拐点",
            "features": {
                "keywords": [
                    "检测需求",
                    "全球疫情",
                    "拐点"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "[天风医药 | 周报】国内或将进一步加大检测需求，全球疫情仍未见拐点",
                "Correlation": 4,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 4,
                "Duration": 5,
                "Entity_Density": 2,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "GSK重组带状疱疹疫苗欣安立适登陆中国 国内多家企业正在追赶",
            "features": {
                "keywords": [
                    "GSK",
                    "重组带状疱疹疫苗",
                    "欣安立适",
                    "国内企业"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "GSK重组带状疱疹疫苗欣安立适登陆中国 国内多家企业正在追赶",
                "Correlation": 3,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 4,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "沃森生物：中国首个mRNA新型冠状病毒疫苗获批进入临床试验阶段",
            "features": {
                "keywords": [
                    "沃森生物",
                    "mRNA疫苗",
                    "临床试验",
                    "新冠病毒"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "沃森生物：中国首个mRNA新型冠状病毒疫苗获批进入临床试验阶段",
                "Correlation": 10,
                "Sentiment": 10,
                "Importance": 10,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 10
            }
        }
    ]
]